Short answer
Globe Life (GL) filed its fiscal 2025 10-K annual report with the SEC on Feb 25, 2026. It reported revenue of $6.0B (+3.7% year over year) and net income of $1.2B.
- Top risk flagged: Legal proceedings costs $13.5M in 2025 and $17M in 2024, indicating ongoing material litigation exposure with no specific resolution timeline
FY2025 key financial metrics · XBRL
- Revenue
- $6.0B
- +3.7% YoY
- Net income
- $1.2B
- +8.4% YoY
- EPS (diluted)
- $14.07
- +17.8% YoY
- ROE
- 19.4%
- −0.7 pp YoY
- Operating cash flow
- $1.4B
- −0.4% YoY
Source: XBRL data from the Globe Life (GL) FY2025 10-K on SEC EDGAR. USD.
Globe Life FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Insurance holding company selling life and supplemental health products to lower-middle-income Americans via direct-to-consumer and exclusive agent channels
- Established Globe Life Re Ltd. in Bermuda in 2025: new affiliated reinsurer registered as Class C insurer under BMA supervision for capital efficiency
- Health insurance annualized premium in force grew to $1.65B in 2025 vs $1.48B in 2024, driven by United American Medicare Supplement (+$125.7M) and Family Heritage (+$41M)
- 3,695 employees (1% decrease YoY); 17,000+ independent contracted agents across U.S., Canada, and New Zealand
- $8M+ in charitable contributions in 2025, focused on children, families, veterans, and seniors
Management Discussion & Analysis
- Total premium $4.9B, up 5% YoY; life premium $3.4B (+3%), health premium $1.5B (+9%)
- Net income $1.16B vs $1.07B; net operating income ROE (ex-AOCI) 16.0% vs prior-year mid-teens target
- Best segment: life underwriting margin $1.51B, 45% of premium vs 41% in 2024; worst: excess investment income $138M, down 16% YoY
- Share repurchases 5.4M shares at $685M avg $126.41/share; quarterly dividend raised to $0.27 in 2025, projected $0.33 in 2026
- 2026 subsidiary dividends and excess cash flows projected lower due to nonrecurring extraordinary dividends of $272M received in 2024–2025
Risk Factors
- Legal proceedings costs $13.5M in 2025 and $17M in 2024, indicating ongoing material litigation exposure with no specific resolution timeline
- Excess investment income fell 16% to $138M in 2025, driven by lower yields on commercial mortgage loans and limited partnerships and constrained asset growth
- American Income Life Division contributes 53% of total life premium ($1.79B), creating heavy single-channel concentration risk
- Medicare Advantage market shift boosted United American health net sales 92%, but underwriting margin compressed to 6% from 8% due to rising claims utilization
- Fixed maturity portfolio 42% BBB-rated at $18.8B amortized cost, with $1.2B net unrealized loss position and effective duration of 8.7 years to next call
Generated from the filing text; verify against the original. How to read a 10-K
Other Globe Life annual reports
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.